文献速递产科母胎医学

早发型胎儿生长受限围产期生存预测:胎盘生长因子的作用

Prediction of perinatal survival in early-onset fetal growth restriction: role of placental growth factor.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

这项前瞻性观察研究纳入210例早发型胎儿生长受限(eoFGR)单胎妊娠,诊断时评估超声参数和血管生成标志物。185例(88.1%)围产期存活,诊断孕周≥28周者全部存活;<28周者中,估计胎儿体重(EFW)与胎盘生长因子(PlGF)中位数倍数(MoM)组合预测围产期生存的AUC为0.84(95%CI 0.75-0.92)。

要点

  • eoFGR诊断时EFW与PlGF MoM组合可较好预测<28周诊断者的围产期生存(AUC 0.84)。
  • 诊断孕周≥28周的eoFGR病例围产期全部存活。
  • 无论何种模型,产前预测严重新生儿发病率的能力均有限(AUC 0.73)。

核心结论

  • 联合EFW与母血清PlGF的模型能准确预测28周前诊断的eoFGR病例的围产期生存。
  • eoFGR严重新生儿发病率的产前预测能力有限,与所用模型无关。

研究设计与样本

  • 前瞻性观察性研究,纳入210例诊断为eoFGR(<32周妊娠)的单胎妊娠。
  • 诊断时完成超声检查(解剖、生物测量和多普勒)及母血清sFlt-1和PlGF检测。
  • 采用逻辑回归模型预测围产期生存(<28周诊断者)和严重新生儿发病率(所有活产病例)。

主要发现

  • 210例eoFGR中185例(88.1%)围产期存活,诊断中位孕周为27+0周。
  • 诊断孕周≥28周的病例全部存活。
  • <28周诊断者中,存活者(对比非存活者)诊断时孕周26.1 vs 24.4周、EFW 626 vs 384 g、脑胎盘比1.1 vs 0.9、PlGF 41 vs 18 pg/mL、PlGF MoM 0.10 vs 0.06,sFlt-1/PlGF比值129 vs 479(均P<0.001)。
  • 预测围产期生存的最佳两变量组合为EFW与PlGF MoM(AUC 0.84,95%CI 0.75-0.92)。
  • EFW与PlGF MoM也是预测严重新生儿发病率的最佳变量(AUC 0.73,95%CI 0.66-0.80)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the ability to predict perinatal survival and severe neonatal morbidity of cases with early-onset fetal growth restriction (eoFGR) using maternal variables, ultrasound parameters and angiogenic markers at the time of diagnosis. METHODS: This was a prospective observational study in a cohort of singleton pregnancies with a diagnosis of eoFGR (< 32 weeks of gestation). At diagnosis of eoFGR, complete assessment was performed, including ultrasound examination (anatomy, biometry and Doppler assessment) and maternal serum measurement of the angiogenic biomarkers, soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF). Logistic regression models for the prediction of perinatal survival (in cases diagnosed at < 28 weeks) and severe neonatal morbidity (in all liveborn cases) were calculated. RESULTS: In total, 210 eoFGR cases were included, of which 185 (88.1%) survived perinatally. The median gestational age at diagnosis was 27 + 0 weeks. All cases diagnosed at ≥ 28 weeks survived. In cases diagnosed < 28 weeks, survivors (vs non-survivors) had a higher gestational age (26.1 vs 24.4 weeks), estimated fetal weight (EFW; 626 vs 384 g), cerebroplacental ratio (1.1 vs 0.9), PlGF (41 vs 18 pg/mL) and PlGF multiples of the median (MoM; 0.10 vs 0.06) and lower sFlt-1/PlGF ratio (129 vs 479) at the time of diagnosis (all P < 0.001). The best combination of two variables for predicting perinatal survival was provided by EFW and PlGF MoM (area under the receiver-operating-characteristics curve (AUC), 0.84 (95% CI, 0.75-0.92)). These were also the best variables for predicting severe neonatal morbidity (AUC, 0.73 (95% CI, 0.66-0.80)). CONCLUSIONS: A model combining EFW and maternal serum PlGF predicts accurately perinatal survival in eoFGR cases diagnosed before 28 weeks of gestation. Prenatal prediction of severe neonatal morbidity in eoFGR cases is modest regardless of the model used. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Calvo J, Villalaín C, Gómez-Arriaga PI, et al. Prediction of perinatal survival in early-onset fetal growth restriction: role of placental growth factor. Ultrasound Obstet Gynecol. 2023. PMID: 36370447. doi:10.1002/uog.26116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。